1,752
Views
6
CrossRef citations to date
0
Altmetric
Research Paper

Short- and long-term follow-up outcomes of patients with Brucella endocarditis: a systematic review of 207 Brucella endocarditis Cases

, , , , &
Pages 5162-5172 | Received 19 May 2021, Accepted 28 Jul 2021, Published online: 18 Aug 2021

References

  • Pappas G, Akritidis N, Bosilkovski M, et al. Brucellosis[J]. N Engl J Med. 2005;352(22):2325–2336.
  • Jlang H, O’callaghan D, Ding JB. Brucellosis in China: history, progress and challenge[J]. Infect Dis Poverty. 2020;9(1):55.
  • Golshani M, Buozari S. A review of brucellosis in iran: epidemiology, risk factors, diagnosis, control, and prevention[J]. PLoS One. 2017;21(6):349–359.
  • Rodr Guez-Alonso B, Almeida H, Alonso-Sard NM, et al. Epidemiological assessment of 5598 brucellosis inpatients in Spain (1997-2015)[J]. Epidemiol Infect. 2021;149:e149.
  • Battikh H, Berriche A, Zayoud R, et al. Clinical and laboratory features of brucellosis in a university hospital in Tunisia[J]. Infect Dis Now. 2021. DOI:10.1016/j.idnow.2021.03.005
  • Amro A, Mansoor B, Hamarsheh O, et al. Recent trends in human brucellosis in the West Bank, Palestine[J]. Int J Infect Dis. 2021;106:308–313.
  • Fritz CL, Nguyen A, Vugia DJ. Epidemiology of brucellosis in California, 1993-2017: a continuing foodborne disease risk for older Latinos[J]. Clin Infect Dis. 2021. DOI:10.1093/cid/ciab551
  • Bayhan G, Tre M, Liang PF, et al. Human distribution and spatial-temporal clustering analysis of human brucellosis in China from 2012 to 2016[J]. Cardiol Young. 2020;9(1):142.
  • Al Jindan R. Scenario of pathogenesis and socioeconomic burden of human brucellosis in Saudi Arabia[J]. Saudi J Biol Sci. 2021;28(1):272–279.
  • Dean AS, Crump L, Greter H, et al. Clinical manifestations of human brucellosis: a systematic review and meta-analysis[J]. PLoS Negl Trop Dis. 2012;6(12):e1929.
  • Chu D-T, Ngoc TU, Chu-Dinh T, et al. The possible zoonotic diseases transferring from pig to human in Vietnam[J]. Eur J Clin Microbiol Infect Dis. 2019;38(6):1003–1014.
  • Peery TM, Belter LF. Brucellosis and heart disease. II. Fatal brucellosis: a review of the literature and report of new cases[J]. Am J Pathol. 1960;36(6):673–697.
  • Alici H, Ercan S, Davutoglu V. Brucella infective endocarditis[J]. Cor Vasa. 2014;56(5):e433–e435.
  • Cahill TJ, Prendergast BD. Infective endocarditis[J]. Lancet. 2016;387(10021):882–893.
  • Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association[J]. Circulation. 2015;132(15):1435–1486.
  • Mohamed Elfadil O, Al-Amri KA, Al-Wahaibi K, et al. Fatal Brucella Endocarditis in a Middle-Aged Male: lessons on Diagnostic and Therapeutic Challenges[J]. SN Compreh Clin Med. 2021;3(1):210–212.
  • Golden B, Layman TE, Koontz FP, et al. Brucella suis endocarditis[J]. South Med J. 1970;63(4):392–395.
  • Keshtkar-Jahromi M, Razavi S-M, Gholamin S, et al. Medical versus medical and surgical treatment for brucella endocarditis[J]. Ann Thorac Surg. 2012;94(6):2141–2146.
  • Solera J, Mart Nez-Alfaro E, Espinosa A, et al. Multivariate model for predicting relapse in human brucellosis[J]. J Infect. 1998;36(1):85–92.
  • Franco MP, Mulder M, Smits HL. Persistence and relapse in brucellosis and need for improved treatment[J]. Trans R Soc Trop Med Hyg. 2007;101(9):854–855.
  • Solera J, Mart Nez-Alfaro E, ESPINOSA A. Recognition and optimum treatment of brucellosis[J]. Drugs. 1997;53(2):245–256.
  • Chairs Astoiesgw C, Pettersson GB, Coselli JS, et al. 2016 The American Association for Thoracic Surgery (AATS) consensus guidelines: surgical treatment of infective endocarditis: executive summary[J]. J Thorac Cardiovasc Surg. 2017;153(6):1241–1258 e1229.
  • Botta L, Bechan R, Yilmaz A, et al. Prosthetic valve endocarditis due to Brucella: successful outcome with a combined strategy[J]. J Cardiovasc Med. 2009;10(3):257–258.
  • Pratt DS, Tenney JH, Bjork CM, et al. Successful treatment of Brucella melitensis endocarditis[J]. Am J Med. 1978;64(5):897–900.
  • Hasanjani Roushan MR, Ebrahimpour S. Human brucellosis: an overview[J]. Caspian J Intern Med. 2015;6(1):46–47.
  • Xu N, Dong X, Yao Y, et al. Improved early detection of focal brucellosis complications with anti-brucella IgG[J]. J Clin Microbiol. 2020;58(10). DOI:10.1128/JCM.00903-20
  • Abegaz TM, Bhagavathul. AAS, Gebreyohannes EA, et al. Short- and long-term outcomes in infective endocarditis patients: a systematic review and meta-analysis[J]. BMC Cardiovasc Disord. 2017;17(1):291.
  • Sannikova IV, Makhinya OV, Maleev VV, et al. Brucellosis in the Stavropol Territory: results of 15-year follow-up of epidemiological and clinical features[J]. Ter Arkh. 2015;87(11):11–17.
  • Ahtela E, Oksi J, Porela P, et al. Trends in occurrence and 30-day mortality of infective endocarditis in adults: population-based registry study in Finland[J]. BMJ Open. 2019;9(4):e026811.
  • Yumuk Z, O’callaghan D. Brucellosis in Turkey; an overview[J]. Inter J Infect Dis. 2012;16(4):e228–e235.
  • Rolnick SJ, Pawloski PA, Hedblom BD, et al. Patient characteristics associated with medication adherence[J]. Clin Med Res. 2013;11(2):54–65.
  • Honish A, Westerfield W, Ashby A, et al. Health-related quality of life and treatment compliance with diabetes care[J]. Dis Manage. 2006;9(4):195–200.
  • Krzystanek M, Krysta K, Janas-Kozik M, et al. Risk factors for noncompliance with antipsychotic medication in long-term treated chronic schizophrenia patients[J]. Psychiatr Danub. 2019;31(Suppl 3):543–548.
  • Giordano GN, Ohlsson H, Kendler KS, et al. Age, period and cohort trends in drug abuse hospitalizations within the total Swedish population (1975-2010)[J]. Drug Alcohol Depend. 2014;134:355–361.
  • Quiroga J, Miralles A, Farinola T, et al. Surgical treatment of Brucella endocarditis[J]. Cardiovasc Surg. 1996;4(2):227–230.
  • Hussain ST, Shrestha NK, Gordon SM, et al. Residual patient, anatomic, and surgical obstacles in treating active left-sided infective endocarditis[J]. J Thorac Cardiovasc Surg. 2014;148(3):981–988.e984.
  • Abedi A-S, Hashempour-Baltork F, Alizadeh AM, et al. The prevalence of Brucella spp. in dairy products in the Middle East region: a systematic review and meta-analysis[J]. Acta Trop. 2020;202:105241.
  • Bosilkovski M, Keramat F. The current therapeutical strategies in human brucellosis[J]. Infection. 2021.
  • Hasanjani Roushan MR, Moulana Z, Mohseni Afshar Z, et al. Risk factors for relapse of human brucellosis[J]. Glob J Health Sci. 2015;8(7):77–82.
  • Kalaycioglu S, Imren Y, Erer D, et al. Brucella endocarditis with repeated mitral valve replacement[J]. J Card Surg. 2005;20(2):189–192.
  • Shakir R. Brucellosis[J]. J Neurol Sci. 2021;420:117280.